Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 140Esophageal Neoplasms 71Pancreatic Neoplasms 42Esophageal Squamous Cell Carcinoma 26Carcinoma, Non-Small-Cell Lung 24Adenocarcinoma Of Esophagus 23Breast Neoplasms 18Neoplasms 15Neoplasm Metastasis 15Colorectal Neoplasms 15Prostatic Neoplasms 11Ovarian Neoplasms 9Melanoma 9Squamous Cell Carcinoma of Head and Neck 8Lung Neoplasms 8Adenocarcinoma 8Sarcoma 7Colonic Neoplasms 7Biliary Tract Neoplasms 7Small Cell Lung Carcinoma 6Parkinson Disease 4, Autosomal Dominant Lewy Body 6Carcinoma, Renal Cell 6Urinary Bladder Neoplasms 5Gastrointestinal Neoplasms 5Gallbladder Neoplasms 5Carcinoma, Hepatocellular 5Uterine Cervical Neoplasms 4Salivary Gland Neoplasms 4Rectal Neoplasms 4Head and Neck Neoplasms 4

Interventions

toripalimab 2Oxaliplatin 2tesetaxel 1indusatumab 1Trastuzumab 1S 1 (combination) 1Nivolumab 1Leucovorin 1Ipilimumab 1GC1118 1Fluorouracil 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma of the Stomach × Docetaxel × Gastrointestinal × Clear all
NCT05715931 2024-09-19

Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma

First Affiliated Hospital of Zhejiang University

Phase 2 Recruiting
30 enrolled
Gastrointestinal

Adenocarcinoma of the Stomach

Data powered by HemOnc (CC BY 4.0) Colophon âš¡